The Impact of Angiotensin Receptor–Neprilysin Inhibitors on Arrhythmias in Patients with Heart Failure: A Systematic Review and Meta-analysis

Angiotensin receptor–neprilysin inhibitor (ARNI) use has become increasingly popular. Current guidelines recommend using ARNI therapy for heart failure with reduced (HFrEF) and preserved ejection fraction (HFpEF). As therapies become more widely available, heart failure-associated burdens such as ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mujadzic, Hata, Prousi, George S., Napier, Rebecca, Siddique, Sultan, Zaman, Ninad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2022
Materias:
Research Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521726/
https://www.ncbi.nlm.nih.gov/pubmed/36196235
http://dx.doi.org/10.19102/icrm.2022.130905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521726/
https://www.ncbi.nlm.nih.gov/pubmed/36196235
http://dx.doi.org/10.19102/icrm.2022.130905

Ejemplares similares